Active	Status	Sponsor type	Region	Phase	Filter
3 Active 3 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ho, Jennifer E
NCT03808922 / 2018-004318-16: Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study	Recruiting	3	274	Europe, US, RoW	DAS181, Placebo, DAS181 COVID-19, DAS181 OL	Ansun Biopharma, Inc.	Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised, COVID-19	08/25	08/25
STOP Flu, NCT04298060: DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19)	Not yet recruiting	2b	280	RoW	DAS181, Placebo	Ansun Biopharma, Inc.	Influenza Infection, SAD-RV Infection and COVID-19	03/21	09/22
Spahillari, Aferdita
NCT05322616: Single-Ascending Dose Study of JK07 in Subjects With HFpEF	Withdrawn	1	56	US	JK07, Matching Placebo	Salubris Biotherapeutics Inc	Heart Failure With Preserved Ejection Fraction	05/23	05/23
Kays, Kyle Richard
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ho, Jennifer E
NCT03808922 / 2018-004318-16: Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study	Recruiting	3	274	Europe, US, RoW	DAS181, Placebo, DAS181 COVID-19, DAS181 OL	Ansun Biopharma, Inc.	Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised, COVID-19	08/25	08/25
STOP Flu, NCT04298060: DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19)	Not yet recruiting	2b	280	RoW	DAS181, Placebo	Ansun Biopharma, Inc.	Influenza Infection, SAD-RV Infection and COVID-19	03/21	09/22
Spahillari, Aferdita
NCT05322616: Single-Ascending Dose Study of JK07 in Subjects With HFpEF	Withdrawn	1	56	US	JK07, Matching Placebo	Salubris Biotherapeutics Inc	Heart Failure With Preserved Ejection Fraction	05/23	05/23
Kays, Kyle Richard
No trials found